The Pharma Data

APRIL 28, 2021

Takeda’s new solid pharmaceutical packaging building in Hikari, Japan, was recognized with the 2021 “Process Intelligence and Innovation” category award. The project at the Hikari site is a four-story building designed to elevate pharmaceutical packaging operations to a new industrial standard.

Packaging 52

Packaging Small Molecule Pharmaceutical Companies Engineering 52

Codon

FEBRUARY 13, 2024

Tom Ireland writes about the companies and technologies that are reimagining phage therapy. Soon after its publication, scientists, journalists, and investors were revisiting ‘phage therapy’ as a promising alternative to our failing antibiotics. Read it on our website here. Illustration by David S. Fast forward to 2023.

Therapies 118

Therapies DNA Virus Clinical Trials 118

Agency IQ

JUNE 7, 2024

Active medical devices fall into these categories: MD 1100 general active medical devices, MD 1200 devices for imaging, MD 1300 monitoring devices, MD 1400 devices for radiation and thermo therapy. Series AIMD 0100 describes all active implantable device types.

Regulations 40

Regulations Compliance Packaging Production 40

The Pharma Data

MAY 13, 2021

I have been training clients since 2004. I came across your package through Eric Cressey’s newsletter (I personally completed his Max Strength program and achieved great results) and immediately bought the webinars. Nutritional Therapy Practitioner. Certified 500 hour Yoga Instructor. Certified Pilates and Cycling Instructor.

Production 52

Production Treatment Vaccine Therapies 52

Agency IQ

APRIL 12, 2024

Directive 2001/83/EC and Regulation (EC) No 726/2004. Additionally, reform package included revisions of the regulations for pediatric medicines and orphan drugs. Member State, with orphan drugs or advanced therapy products’ requirements limited to the applicable patient population. citizens; 2.

Pharmaceuticals 40

Pharmaceuticals Regulations Packaging Production 40

Agency IQ

JULY 28, 2023

That law built upon several other previous laws, including the Public Health Threats and Emergencies Act of 2000, the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 and the Project BioShield Act of 2004. But despite the law’s age, it is not yet fully operational.

FDA 40

FDA Science Biosimilars Regulations 40

Drug & Device Law

MAY 30, 2022

The plaintiffs’ causation allegations foundered in Himes because the treating physician did not believe that the claimed risks of electroconvulsive therapy were all that big of a deal, and thus did not warn about it. 2004) (another case we discussed in 2008 ), because the plaintiff failed to “produce[] evidence that the risk. . .

Testimonials 59

Testimonials Doctors Production Laboratories 59